UB Paderborn / Katalog / Suche / in CDI

Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia

PloS one, 2022-09, Vol.17 (9), p.e0274984-e0274984

2022

Link zum Volltext

Verfügbarkeit prüfen

Aspergillus fumigatus Empyema

Archivos de bronconeumología (English ed.), 2017-07, Vol.53 (7), p.399-400

2017

Link zum Volltext

Verfügbarkeit prüfen

Empiema por Aspergillus fumigatus

Archivos de bronconeumología, 2017-07, Vol.53 (7), p.399-400

2017

Link zum Volltext

Verfügbarkeit prüfen

P967: A MACHINE LEARNING MODEL FOR RISK PREDICTION IN MULTIPLE MYELOMA PROGRESSING AFTER THE FIRST LINE OF THERAPY

HemaSphere, 2023-08, Vol.7 (S3), p.e58012ca-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

PB2384: EVALUATION OF NEW MACHINE LEARNING SYSTEMS FOR PROGNOSTICATION BASED ON GENE EXPRESSION SIGNATURES IN MANTLE CELL AND PERIPHERAL T CELL LYMPHOMAS

HemaSphere, 2023-08, Vol.7 (S3), p.e681104f-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

P1234: A PROGNOSTIC MODEL BASED ON GENE EXPRESSION PARAMETERS PREDICTS A BETTER RESPONSE TO BORTEZOMIB‐CONTAINING IMMUNOCHEMOTHERAPY IN DIFFUSE LARGE B‐CELL LYMPHOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e2637897-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Immune Biomarkers of Survival and Severe Infection in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with the Backbone Regimen Lenalidomide and Dexamethasone (Rd)

Blood, 2022-11, Vol.140 (Supplement 1), p.4200-4203

2022

Link zum Volltext

Verfügbarkeit prüfen

P-367 High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S241-S242

2023

Link zum Volltext

Verfügbarkeit prüfen

Aspergillus Fumigatus Empyema

Archivos de bronconeumologia, 2017, Vol.53 (7), p.399-400

2017

Link zum Volltext

Verfügbarkeit prüfen

Intention to use physical restraint in paediatric intensive care units and correlated variables: A multicentre and cross-sectional study

Intensive & critical care nursing, 2024-08, Vol.83, p.103690-103690, Article 103690

2024

Link zum Volltext

Verfügbarkeit prüfen

Avances en tumores del estroma gastrointestinal: ¿hacia dónde vamos?

Cirugia y cirujanos, 2022-04, Vol.90 (2)

2022

Link zum Volltext

Verfügbarkeit prüfen

Revisión de los criterios de distribución de trasplante cardiaco en España en 2023. Documento de consenso SEC-Asociación de Insuficiencia Cardiaca/ONT/SECCE

Revista española de cardiologia, 2024-01, Vol.77 (1), p.69-78

2024

Link zum Volltext

Verfügbarkeit prüfen

Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders

Mitochondrion, 2016-09, Vol.30, p.51-58

2016

Link zum Volltext

Verfügbarkeit prüfen

CTIM-08. SAFETY, EFFICACY, AND SURVIVAL RESULTS FROM A PHASE 1 STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 FOLLOWED BY STANDARD OF CARE RADIOTHERAPY FOR NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi50-vi51

2021

Link zum Volltext

Verfügbarkeit prüfen

Term planned delivery based on fetal growth assessment with or without the cerebroplacental ratio in low-risk pregnancies (RATIO37): an international, multicentre, open-label, randomised controlled trial

The Lancet (British edition), 2024-02, Vol.403 (10426), p.545-553

2024

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Lenalidomide and Dexamethasone Versus Clarythromycin, Lenalidomide and Dexamethasone As First Line Treatment in Patients with Multiple Myeloma Not Candidates for Autologous Stem Cell Transplantation: Results of the GEM-Claridex Clinical Trial

Blood, 2019-11, Vol.134 (Supplement_1), p.694-694

2019

Link zum Volltext

Verfügbarkeit prüfen

CTIM-25. ONCOLYTIC VIRUS FOR DIPG: THE CLINICAL EXPERIENCE WITH DNX-2401

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii38-ii38

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia

Aspergillus fumigatus Empyema

Empiema por Aspergillus fumigatus

Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia

P967: A MACHINE LEARNING MODEL FOR RISK PREDICTION IN MULTIPLE MYELOMA PROGRESSING AFTER THE FIRST LINE OF THERAPY

P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB‐BORTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF RELAPSE OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF THE PHASE 2, MULTICENTER GEM‐SELIBORDARA STUDY

PB2384: EVALUATION OF NEW MACHINE LEARNING SYSTEMS FOR PROGNOSTICATION BASED ON GENE EXPRESSION SIGNATURES IN MANTLE CELL AND PERIPHERAL T CELL LYMPHOMAS

P1234: A PROGNOSTIC MODEL BASED ON GENE EXPRESSION PARAMETERS PREDICTS A BETTER RESPONSE TO BORTEZOMIB‐CONTAINING IMMUNOCHEMOTHERAPY IN DIFFUSE LARGE B‐CELL LYMPHOMA

Immune Biomarkers of Survival and Severe Infection in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with the Backbone Regimen Lenalidomide and Dexamethasone (Rd)

Multiomics Profiling of Measurable Residual Disease (MRD) for Understanding the Biology of Ultra-Drug Resistance in Multiple Myeloma (MM)

OA-12 Predictors of unsustained measurable residual disease (MRD) negativity in transplant-eligible multiple myeloma (MM) patients

P-367 High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience

Aspergillus Fumigatus Empyema

Outcomes of Cord Blood Transplantation Using Reduced Intensity Conditioning for Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of Eurocord, SFGM-TC and Cqwp-EBMT

P1480: CLINICAL AND GENETIC STUDY OF HEREDITARY SPHEROCYTOSIS IN THE SPANISH POPULATION

Intention to use physical restraint in paediatric intensive care units and correlated variables: A multicentre and cross-sectional study

Avances en tumores del estroma gastrointestinal: ¿hacia dónde vamos?

Revisión de los criterios de distribución de trasplante cardiaco en España en 2023. Documento de consenso SEC-Asociación de Insuficiencia Cardiaca/ONT/SECCE

OAB-050: Randomized phase 2 study of weekly carfilzomib 70 mg/m2 and dexamethasone plus/minus cyclophosphamide in relapsed and/or refractory multiple (MM) patients (GEMKyCyDex)

Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders

CTIM-08. SAFETY, EFFICACY, AND SURVIVAL RESULTS FROM A PHASE 1 STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 FOLLOWED BY STANDARD OF CARE RADIOTHERAPY FOR NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

Term planned delivery based on fetal growth assessment with or without the cerebroplacental ratio in low-risk pregnancies (RATIO37): an international, multicentre, open-label, randomised controlled trial

CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumonia e and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

Randomized Trial of Lenalidomide and Dexamethasone Versus Clarythromycin, Lenalidomide and Dexamethasone As First Line Treatment in Patients with Multiple Myeloma Not Candidates for Autologous Stem Cell Transplantation: Results of the GEM-Claridex Clinical Trial

CTIM-25. ONCOLYTIC VIRUS FOR DIPG: THE CLINICAL EXPERIENCE WITH DNX-2401

Aktive Filter

Suchergebnisse filtern